MTOR and Tako-tsubo cardiomyopathy: Similarly, mTOR inhibition in TSC patients has shown improvements for epileptic symptoms (Mizuguchi et al., 2019) but not for ASD-associated behaviors (Overwater et al., 2019), suggesting that treatment must be given in the critical period or that mTOR signaling is less important in ASC symptoms in humans.